A Study to Investigate the Effects of JMKX003142 on QTc Interval in Healthy Adults

Summary

The primary objective of this study is to assess the effect of a therapeutic and supratherapeutic oral dose of JMKX003142 on the corrected cardiac QT interval relative to a placebo in healthy participants

Timeline

Start

2026-03-27

Primary completion

2026-05-14

Completion

2026-06-23

Drugs

Indications